Growing Demand for Interventional Oncology Devices to Boost the Growth of Interventional Oncology Devices Market

 

North America currently holds the largest market share in terms of revenue generation. North America interventional oncology devices market was valuedat$965.90million in 2018. High prevalence of cancer, growing geriatric population, and high reimbursement rates are the prominent factors propelling the growth of the North America interventional oncology devices market. However, the market for interventional oncology devices market in Asia-Pacific is anticipated to witness the highest growth rate during the forecast period. The massive demand for interventional oncology devices, large geriatric population base, demand for minimally invasive and non-invasive surgical procedures, and high prevalence rates of cancer, is the leading contributor to the growth of the Asia-Pacific interventional oncology devices market.

The interventional oncology devices market in economies such as Japan, China, India, and South Korea, among others possesses significant scope for the expansion of operations by key players of the interventional oncology industry. The countries mentioned above witnessed high incidence of cancer, and the rise of the massive demand for interventional oncology devices is bolstered by the large proportion of the geriatric population of the respective economies. However, the lack of favourable reimbursement policies is hampering the growth of the interventional oncology devices market.

The strategies followed by various prominent companies, to sustain in the competition and expand their market share, have been varying from product launch to acquisitions. The market witnessed two business expansions, fourteen product launches, seven significant acquisitions and mergers, three collaborations, joint ventures, and partnerships, and two awards and recognitions. The key contributors to the global interventional oncology devices market have been launching innovative products and have been involved in mergers and acquisitions to sustain in the intensely competitive market. In correlation with the high prevalence of cancer, North America is currently the largest shareholder, in terms of revenue generation.